IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1601 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration

Gupta Pooja, Gupta Veena, Gupta Yogendra K

Year : 2012| Volume: 44| Issue : 4 | Page no: 540-542

   This article has been cited by
1 Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
Igor Radanovic, Naomi Klarenbeek, Robert Rissmann, Geert Jan Groeneveld, Emilie M. J. van Brummelen, Matthijs Moerland, Jacobus J. Bosch
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
2 A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker
Christine Huynh, Andrea Henrich, Daniel S. Strasser, Marie-Laure Boof, Mohamed Al-Ibrahim, Henriette E. Meyer Zu Schwabedissen, Jasper Dingemanse, Mike Ufer
Clinical Pharmacology & Therapeutics. 2021; 109(6): 1648
[Pubmed]  [Google Scholar] [DOI]
3 Healthy volunteers in first-in-human oncology drug development for small molecules
Begoña de las Heras, Dalila Bouyoucef-Cherchalli, Lesley Reeve, Andreas Reichl, Debra Mandarino, Stephen Flach, Laura Vidal, Emilie M. J. van Brummelen, Neeltje Steeghs
British Journal of Clinical Pharmacology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 A Clinical Review of Biosimilars Approved in Oncology
Dat Ngo, Jason Chen
Annals of Pharmacotherapy. 2021; 55(3): 362
[Pubmed]  [Google Scholar] [DOI]
5 Unveiling changes in the landscape of patient populations in cancer early drug development
Cinta Hierro, Analía Azaro, Guillem Argilés, Elena Elez, Patricia Gómez, Joan Carles, Jordi Rodon
Oncotarget. 2017; 8(8): 14158
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow